These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 884667

  • 21. Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid.
    Lin G, Cui YY, Hawes EM.
    Drug Metab Dispos; 2000 Dec; 28(12):1475-83. PubMed ID: 11095586
    [Abstract] [Full Text] [Related]

  • 22. ¹H NMR study of monocrotaline and its metabolites in human blood.
    Yang YC, Crowder J, Wardle NJ, Yang L, White KN, Wang ZT, Annie Bligh SW.
    Food Chem Toxicol; 2011 Nov; 49(11):2793-9. PubMed ID: 21843583
    [Abstract] [Full Text] [Related]

  • 23. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine.
    Xia Q, Chou MW, Edgar JA, Doerge DR, Fu PP.
    Cancer Lett; 2006 Jan 08; 231(1):138-45. PubMed ID: 16356839
    [Abstract] [Full Text] [Related]

  • 24. Crosslinking of DNA by dehydroretronecine, a metabolite of pyrrolizidine alkaloids.
    Reed RL, Ahern KG, Pearson GD, Buhler DR.
    Carcinogenesis; 1988 Aug 08; 9(8):1355-61. PubMed ID: 3402032
    [Abstract] [Full Text] [Related]

  • 25. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.
    Chou MW, Jian Y, Williams LD, Xia Q, Churchwell M, Doerge DR, Fu PP.
    Chem Res Toxicol; 2003 Sep 08; 16(9):1130-7. PubMed ID: 12971801
    [Abstract] [Full Text] [Related]

  • 26. Carcinogenicity of some pyrrolic pyrrolizidine alkaloid metabolites and analogues.
    Mattocks AR, Cabral JR.
    Cancer Lett; 1982 Oct 08; 17(1):61-6. PubMed ID: 6817913
    [Abstract] [Full Text] [Related]

  • 27. The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium.
    Huxtable R, Ciaramitaro D, Eisenstein D.
    Mol Pharmacol; 1978 Nov 08; 14(6):1189-203. PubMed ID: 732815
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation in vitro of several pyrrolizidine alkaloid carcinogens: observations on the essential pyrrolic nucleus.
    Styles J, Ashby J, Mattocks AR.
    Carcinogenesis; 1980 Feb 08; 1(2):161-4. PubMed ID: 22282996
    [Abstract] [Full Text] [Related]

  • 29. Reaction of dehydropyrrolizidine alkaloids with valine and hemoglobin.
    Zhao Y, Wang S, Xia Q, Gamboa da Costa G, Doerge DR, Cai L, Fu PP.
    Chem Res Toxicol; 2014 Oct 20; 27(10):1720-31. PubMed ID: 25211425
    [Abstract] [Full Text] [Related]

  • 30. Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids.
    Mattocks AR, Jukes R, Brown J.
    Toxicon; 1989 Oct 20; 27(5):561-7. PubMed ID: 2749755
    [Abstract] [Full Text] [Related]

  • 31. Sulfhydryl-selective, covalent labeling of biomolecules with transition metallocarbonyl complexes. Synthesis of (eta5-C5H5)M(CO)3(eta1-N-maleimidato) (M = Mo, W), X-ray structure, and reactivity studies.
    Rudolf B, Palusiak M, Zakrzewski J, Salmain M, Jaouen G.
    Bioconjug Chem; 2005 Oct 20; 16(5):1218-24. PubMed ID: 16173801
    [Abstract] [Full Text] [Related]

  • 32. Metabolism of [14C]monocrotaline by isolated perfused rat liver.
    Lamé MW, Jones AD, Morin D, Segall HJ.
    Drug Metab Dispos; 1991 Oct 20; 19(2):516-24. PubMed ID: 1676664
    [Abstract] [Full Text] [Related]

  • 33. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2.
    Ishii T, Uchida K.
    Chem Res Toxicol; 2004 Oct 20; 17(10):1313-22. PubMed ID: 15487891
    [Abstract] [Full Text] [Related]

  • 34. Antimitotic activity of dehydroretronecine, a pyrrolizidine alkaloid metabolite, and some analogous compounds, in a rat liver parenchymal cell line.
    Mattocks AR, Legg RF.
    Chem Biol Interact; 1980 Jun 20; 30(3):325-36. PubMed ID: 7379211
    [Abstract] [Full Text] [Related]

  • 35. S-thiolation mimicry: quantitative and kinetic analysis of redox status of protein cysteines by glutathione-affinity chromatography.
    Niture SK, Velu CS, Bailey NI, Srivenugopal KS.
    Arch Biochem Biophys; 2005 Dec 15; 444(2):174-84. PubMed ID: 16297848
    [Abstract] [Full Text] [Related]

  • 36. The effect of the hepatotoxic pyrrolizidine alkaloid, retrorsine, on bile composition in the rat in vivo.
    Yan CC, Huxtable RJ.
    Proc West Pharmacol Soc; 1996 Dec 15; 39():19-22. PubMed ID: 8895956
    [No Abstract] [Full Text] [Related]

  • 37. [S-Alkylmercapto groups for protection of the SH-function of cysteine. II. Thiol-disulfide exchange of asymmetric disulfides of cysteine].
    Weber U, Hartter P, Flohé L.
    Hoppe Seylers Z Physiol Chem; 1970 Nov 15; 351(11):1389-94. PubMed ID: 5479830
    [No Abstract] [Full Text] [Related]

  • 38. The reaction of Cytembena with cellular thiol compounds.
    Jackson RC, Taylor GA, Harrap KR.
    Neoplasma; 1976 Nov 15; 23(4):355-62. PubMed ID: 1036760
    [Abstract] [Full Text] [Related]

  • 39. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J, Xia Q, Chou MW, Fu PP.
    Toxicol Ind Health; 2008 Apr 15; 24(3):181-8. PubMed ID: 18842697
    [Abstract] [Full Text] [Related]

  • 40. Structural influences on pyrrolizidine alkaloid-induced cytopathology.
    Kim HY, Stermitz FR, Molyneux RJ, Wilson DW, Taylor D, Coulombe RA.
    Toxicol Appl Pharmacol; 1993 Sep 15; 122(1):61-9. PubMed ID: 8378933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.